Regulatory compliance – Page 42

Validation gaps identified during lifecycle management – risk-based validation alignment

Addressing Validation Gaps in Lifecycle Management for Regulatory Compliance In today’s complex pharmaceutical manufacturing landscape, identifying validation gaps during lifecycle management is crucial for maintaining regulatory compliance. Such gaps can…

Hybrid paper-electronic workflows uncontrolled during system upgrade – preventing repeat Part 11 findings

Managing Uncontrolled Hybrid Paper-Electronic Workflows During System Upgrades The rapid digital transformation in pharmaceutical operations has fostered hybrid workflows that combine paper and electronic systems. However, improperly managed transitions can…

Validation gaps identified during site expansion – risk-based validation alignment

Addressing Validation Gaps During Site Expansion: A Comprehensive Playbook In the dynamic environment of pharmaceutical manufacturing, site expansions can pose significant challenges, particularly when it comes to maintaining compliance with…

Hybrid paper-electronic workflows uncontrolled during validation lifecycle – preventing repeat Part 11 findings

Managing Uncontrolled Hybrid Paper-Electronic Workflows During Validation to Prevent Part 11 Findings In the rapidly evolving landscape of pharmaceutical manufacturing and regulatory compliance, addressing the challenges posed by hybrid paper-electronic…

Validation gaps identified during site expansion – CAPA and revalidation strategy

Addressing Validation Gaps Encountered During Site Expansion: A Hands-On CAPA and Revalidation Guide Validation gaps often emerge during a site expansion project, potentially jeopardizing compliance and product quality. For pharmaceutical…

Record retention failures during compliance audit – preventing repeat Part 11 findings

Preventing Repeat Findings from Record Retention Failures in Compliance Audits During compliance audits, record retention failures can trigger non-compliance issues, particularly related to 21 CFR Part 11 regarding electronic records.…

Validation gaps identified during change control – risk-based validation alignment

Mitigating Validation Gaps Found During Change Control: A Comprehensive Playbook Validation gaps identified during change control can lead to significant compliance and quality issues in pharmaceutical manufacturing. They often result…

System access controls weak during validation lifecycle – preventing repeat Part 11 findings

Strengthening System Access Controls Throughout the Validation Lifecycle Pharmaceutical companies often face challenges related to system access controls, particularly during the validation lifecycle. Weak access controls can lead to significant…

CSV compliance weak during lifecycle management – risk-based validation alignment

Enhancing CSV Compliance Throughout Lifecycle Management for Regulatory Readiness Pharmaceutical manufacturing often grapples with the challenge of maintaining compliance in computer system validation (CSV) during the lifecycle of software and…

ERES controls not implemented during inspection walkthrough – CAPA and revalidation strategy

Strategies for Addressing ERES Control Failures During Inspection Walkthroughs When regulatory inspectors notice lapses in electronic records and electronic signatures (ERES) controls during walkthroughs, it poses a significant risk for…

Incomplete validation lifecycle during inspection readiness – risk-based validation alignment

Mitigating Risks of Incomplete Validation Lifecycles for Inspection Readiness In the pharmaceutical manufacturing landscape, maintaining compliant operational standards is critical. One pressing issue is managing the risks associated with an…

Record retention failures during inspection walkthrough – preventing repeat Part 11 findings

Preventing Record Retention Failures During Inspection Walkthroughs In the highly regulated pharmaceutical industry, maintaining adequate record retention practices is crucial for compliance during inspections. Given the heightened scrutiny from regulatory…